STAT+ reveals hidden issues in FDA's AI medical device approval pathway

Brittany Trang, a health‑tech reporter, published a STAT+ newsletter piece that examines how the FDA handles AI‑driven medical devices. The article highlights the lack of transparency in the agency's most frequently used approval route for these technologies.

The discussion centers on the peculiarities of the pathway, including how sepsis‑detection algorithms are evaluated. Trang points out that the process can obscure important safety and performance details, raising concerns for clinicians and patients.

The piece is available only to STAT+ subscribers and forms part of the outlet's broader coverage of AI's role in health care. It also mentions the upcoming STAT Breakthrough West Summit in San Francisco, where the author will be present to discuss AI and data topics.

Readers are encouraged to contact the reporter for further dialogue or to arrange meetings at the summit, underscoring the ongoing conversation about AI regulation in medicine.